Iovance Biotherapeutics, Inc.
IOVANASDAQHealthcare● Active
$4.00
$-0.24(-5.56%)
Market Cap$1.4B
P/E Ratio—
52W High$5.63
52W Low$1.66
Iovance Biotherapeutics, Inc.（IOVA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IOVA · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.26B | $0.16B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.01B | $0.12B | $0.01B | $0.00B | $0.00B |
| Gross Profit | $0.26B | $0.04B | ($0.01B) | $0.00B | $0.00B |
| Gross Margin %(computed) | 97.23% | 24.43% | -804.54% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.30B | $0.28B | $0.34B | $0.29B | $0.26B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.10B | $0.08B |
| Total Operating Expenses | $0.66B | $0.44B | $0.45B | $0.40B | $0.34B |
| Operating Income | ($0.40B) | ($0.40B) | ($0.46B) | ($0.40B) | ($0.34B) |
| Operating Margin %(computed) | -153.08% | -240.92% | — | — | — |
| Interest Income | $0.00B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.39B) | ($0.38B) | ($0.45B) | ($0.40B) | ($0.34B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | $0.00B |
| Net Income | ($0.39B) | ($0.37B) | ($0.44B) | ($0.40B) | ($0.34B) |
| Net Margin %(computed) | -148.38% | -226.84% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 |
| Wtd Avg Shares | 0.36B | 0.29B | 0.24B | 0.16B | 0.15B |
| EBITDA | ($0.36B) | ($0.35B) | ($0.43B) | ($0.38B) | ($0.33B) |
| EBITDA Margin %(computed) | -135.52% | -214.34% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Iovance Biotherapeutics, Inc.
关于Iovance Biotherapeutics, Inc.（IOVA）损益表
Iovance Biotherapeutics, Inc.（IOVA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，IOVA实现营收$0.26B，毛利润$0.26B（毛利率97.23%），净利润($0.39B)（净利率-148.38%）。
常见问题
IOVA · 4 问Iovance Biotherapeutics, Inc.（IOVA）2025财年营收为$0.26B，同比up60.6%。
IOVA revenueIOVA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08